肩峰下撞击综合征非手术治疗中增加大剂量肩部力量训练的效果:SExSI实用双盲随机对照试验
该实用双盲随机对照试验将200例肩峰下撞击综合征患者随机分入常规非手术治疗组或常规治疗加大剂量肩部力量训练组,主要结局为4个月时SPADI评分。意向性治疗和符合方案分析均显示两组在任何结局上无显著或临床相关差异,约半数患者未达到可接受症状状态。
要点
- 增加大剂量肩部力量训练未改善肩峰下撞击综合征患者的肩部特异性患者报告结局。
- 两组SPADI均改善约22分,组间平均差异仅0.6分(95%CI -5.5至6.6)。
核心结论
- 在常规非手术治疗基础上增加大剂量肩部力量训练,未能在肩峰下撞击综合征患者中产生更优的肩部特异性患者报告结局。
研究设计与样本
- 实用双盲随机对照试验,证据等级1,纳入200例因长期肩痛(>3个月)转诊至骨科肩关节专科、年龄18至65岁且按经验证标准诊断为肩峰下撞击综合征的连续患者。
主要发现
- 意向性治疗和符合方案分析均显示两组在任何结局上无显著或临床相关差异。
- 从基线至4个月随访,两组SPADI评分均改善:干预组-22.1分,对照组-22.7分,组间平均差异0.6分(95%CI -5.5至6.6)。
- 未报告严重不良事件。
关键数值与推荐
- 主要结局为4个月随访时的肩痛与残疾指数(SPADI;0-100),最小临床重要差异定义为10分。
临床怎么用
- 对于肩峰下撞击综合征患者,在常规非手术治疗中额外增加大剂量肩部力量训练并非改善结局的有效方案。
- 临床应关注约半数患者经4个月非手术治疗仍未达到可接受症状状态,需探索其他解决策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A strong recommendation against subacromial decompression surgery was issued in 2019. This leaves nonoperative care as the only treatment option, but recent studies suggest that the dose of strengthening exercise is not sufficient in current nonoperative care. At this point, it is unknown if adding more strengthening to current nonoperative care is of clinical value. PURPOSE: To assess the effectiveness of adding a large dose of shoulder strengthening to current nonoperative care for subacromial impingement compared with usual care alone. STUDY DESIGN: Randomized controlled trial; Level of evidence, 1. METHODS: In this double-blinded, pragmatic randomized controlled trial, we randomly allocated 200 consecutive patients referred to orthopaedic shoulder specialist care for long-standing shoulder pain (>3 months), aged 18 to 65 years and diagnosed with subacromial impingement using validated criteria, to the intervention group (IG) or control group (CG). Outcome assessors were blinded, and participants were blinded to the study hypothesis as well as to the treatment method in the other group. The CG received usual nonoperative care; the IG underwent the same plus an add-on intervention designed to at least double the total dose of shoulder strengthening. The primary outcome was the Shoulder Pain and Disability Index (SPADI; 0-100) at 4-month follow-up, with 10 points defined as the minimal clinically important difference. Secondary outcomes included shoulder strength, range of motion, health-related quality of life, and the Patient Acceptable Symptom State (PASS). RESULTS: Intention-to-treat and per-protocol analyses showed no significant or clinically relevant between-group differences for any outcome. From baseline to 4-month follow-up, SPADI scores improved in both groups (intention-to-treat analysis; IG, -22.1 points; CG, -22.7 points; between-group mean difference, 0.6 points [95% CI, -5.5 to 6.6]). At 4 months after randomization, only 54% of the IG and 48% of the CG (P = .4127) reached the PASS. No serious adverse events were reported. CONCLUSION: Adding a large dose of shoulder strengthening to current nonoperative care for patients with subacromial impingement did not result in superior shoulder-specific patient-reported outcomes. Moreover, approximately half of all randomized patients did not achieve the PASS after 4 months of nonoperative care, leaving many of these patients with unacceptable symptoms. This study showed that adding more exercise is not a viable solution to this problem. REGISTRATION: NCT02747251 (ClinicalTrials.gov identifier).
引用
- Clausen MB, Hölmich P, Rathleff M, et al. Effectiveness of Adding a Large Dose of Shoulder Strengthening to Current Nonoperative Care for Subacromial Impingement: A Pragmatic, Double-Blind Randomized Controlled Trial (SExSI Trial). Am J Sports Med. 2021. PMID: 34048281. doi:10.1177/03635465211016008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。